Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy

• aPTT correlates poorly with anti-Xa in COVID-19 patients receiving unfractionated heparin. • aPTT potentially underestimates heparin activity compared with anti-Xa in COVID-19 patients receiving unfractionated heparin. • Elevated fibrinogen levels did not correlate with refractory aPTT in COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawlor, Matthew, Gupta, Aakriti, Ranard, Lauren S., Madhavan, Mahesh V., Li, Jianhua, Eisenberger, Andrew, Parikh, Sahil A., Sethi, Sanjum S., Masoumi, Amirali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Letter to the Editors-in-Chief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698679/
https://www.ncbi.nlm.nih.gov/pubmed/33302210
http://dx.doi.org/10.1016/j.thromres.2020.11.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698679/
https://www.ncbi.nlm.nih.gov/pubmed/33302210
http://dx.doi.org/10.1016/j.thromres.2020.11.030

Ejemplares similares